ENDALIS

ENDALIS

ENDALIS has developed END BALL, a non-surgical, temporary intragastric balloon system for the treatment of obesity. The intragastric balloon acts through the filling of the stomach which causes a feeling of satiety and a reduction of food intake. Its duration of use is less than or equal to 6 months and is intended to allow weight loss when a monitored weight loss program has not been sufficient.T he END BALL gatsric balloon is distributed around the world.

Company details

1 Allée des Tilleuls, Brignais, 69530 

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Medical Equipment
Market Focus:
Globally (various continents)
Year Founded:
2007